Clinical Trials on Breast Cancer Stage IIIA in Germany
Total 618 results
-
German Breast GroupRoche Pharma AG; Celgene CorporationCompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
German Breast GroupCelgene Corporation; AmgenCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor PharmaCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
German Breast GroupGlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USACompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
European Organisation for Research and Treatment...Pfizer; ETOP IBCSG Partners Foundation; UNICANCER; Breast International Group; SOLTI... and other collaboratorsActive, not recruitingBreast Cancer Stage II | Breast Cancer Stage IIISpain, France, Italy, Belgium, Jordan, Poland, Germany, United Kingdom, Portugal
-
European Organisation for Research and Treatment...Breast International Group; Menarini GroupRecruitingStage IIB Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Stage III Breast CancerBelgium, Italy, Ireland, France, Germany
-
AIO-Studien-gGmbHAstraZenecaTerminatedNSCLC | Non-squamous Non-small Cell Lung Cancer Stage II | Non-squamous Non-small Cell Lung Cancer Stage IIIA | Non-squamous Non-small Cell Lung Cancer Stage IIIB | Activating EGFR MutationGermany
-
Kliniken Essen-MitteGerman Breast GroupCompletedEarly Stage Breast CancerGermany
-
University Hospital HeidelbergDietmar Hopp StiftungRecruitingNSCLC Stage IIIB | NSCLC Stage II | NSCLC, Stage IIIAGermany
-
German Cancer Research CenterGerman Federal Ministry of Education and Research; University Hospital HeidelbergRecruitingNeoadjuvant Therapy | Early-Stage Breast CancerGermany
-
German Cancer Research CenterRecruitingEarly-stage Breast CancerGermany
-
University Hospital, EssenGerman Cancer AidNot yet recruitingAdvanced Lung Carcinoma | NSCLC Stage IV | NSCLC Stage IIIB | First Line Treatment | Second Line Treatment | Palliative Treatment | NSCLC Stage IIICGermany
-
Johannes Gutenberg University MainzCompletedRectal Cancer Stage II | Rectal Cancer Stage IIIGermany
-
University Hospital TuebingenRecruitingRectal Cancer | Rectal Neoplasms | Rectal Cancer Stage II | Rectal Cancer Stage IIIGermany
-
Charite University, Berlin, GermanyKlinikum rechts der Isar, TU München, (TUM), Munich, Germany.RecruitingSarcoma | Prostate Cancer | Pancreatic Cancer Stage IV | Breast Cancer Stage IV | Squamous Cell Carcinoma | Melanoma Stage IVGermany
-
University Hospital, EssenRecruitingNSCLC, Stage I | NSCLC Stage II | NSCLC, Stage IIIABelgium, Germany, Netherlands
-
Ludwig-Maximilians - University of MunichPierre Fabre LaboratoriesCompletedCarcinoma Breast Stage IVGermany
-
AIO-Studien-gGmbHBristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaboratorsRecruitingSmall-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage IIGermany
-
Prof. Dr. med. Claus RödelJohann Wolfgang Goethe University Hospital; Deutsche Krebshilfe e.V., Bonn...CompletedRectal Neoplasms | Rectal Cancer Stage II | Rectal Cancer Stage IIIGermany
-
Palleos Healthcare GmbHRoche Pharma AG; University Hospital, Essen; University Hospital Erlangen; Phaon...Active, not recruitingTriple-negative Breast CancerGermany
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Greece, Spain, United States, Israel, France, Japan, Belgium, Poland, China, Singapore, Australia, Hungary, Czechia, Italy, South Africa, Hong Kong, Chile, Brazil, Argentina, Austria, Canada, Germany, Portugal, United Kingdom
-
Technical University of MunichEli Lilly and CompanyRecruitingBreast Cancer/ Metastatic Breast CancerGermany
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingTNBC - Triple-Negative Breast CancerGermany
-
Technical University of MunichCompleted
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; iOMEDICO AGCompletedHer2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast CancerGermany
-
German Breast GroupPfizerCompletedMale Breast CancerGermany
-
Heidelberg UniversityDafra Pharma; Hector-Stiftung; Monika-Kutzner Stiftung, Berlin, Germany; HEIFAN-Heidelberger...CompletedMetastatic Breast Cancer | Locally Advanced Breast CancerGermany
-
German Breast GroupCompleted
-
German Breast GroupTerminatedMetastatic Breast CancerGermany
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
Kliniken Essen-MitteRecruitingPrimary Breast CancerGermany
-
Prof. W. JanniRoche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbHRecruiting
-
University Hospital TuebingenPaul Ehrlich Institute, Langen, GermanyCompletedMetastatic Breast CancerGermany
-
German Breast GroupCompletedBreast Cancer MetastaticGermany
-
University of JenaCompleted
-
iOMEDICO AGRoche Pharma AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis...CompletedMetastatic Breast CancerGermany
-
NovartisCompletedMetastatic Breast CancerGermany
-
West German Study GroupCelgeneActive, not recruiting
-
Kliniken Essen-MitteRecruitingBreast Cancer | Node-positive Breast CancerGermany
-
RWTH Aachen UniversityUniv.-Prof. Dr. med. F. KiesslingUnknown
-
Institut fuer FrauengesundheitEisai GmbHRecruitingAssessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (AIRE)Breast Cancer Female | Breast Cancer Metastatic | Neoplasm, BreastGermany
-
German Breast GroupBoehringer IngelheimCompleted
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerGermany
-
RWTH Aachen UniversityRecruiting
-
BioNTech SESeventh Framework ProgrammeCompletedBreast Cancer (Triple Negative Breast Cancer (TNBC))Sweden, Germany
-
iOMEDICO AGAmgen; Arbeitsgemeinschaft fur Internistische OnkologieWithdrawnAdvanced Breast Cancer | HER2-positive Breast CancerGermany
-
West German Study GroupSanofi; AmgenCompletedPrimary Breast Cancer | Her2 Non-overexpressingGermany
-
University Hospital TuebingenCompletedBreast Cancer SurgeryGermany
-
German Breast GroupCompletedMetastatic Breast CancerGermany
-
WiSP Wissenschaftlicher Service Pharma GmbHBristol-Myers Squibb; Roche Pharma AGCompleted